AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 16791523 — intervention group
Group type: EXPERIMENTAL
Intervention: Iowa Strengthening Families Program (ISFP)
Number of subjects: 0
Study 16791523 — intervention group
Group type: EXPERIMENTAL
Intervention: Preparing for the Drug Free Years program (PDFY)
Number of subjects: 0
Study 16791523 — intervention group
Group type: COMPARATOR
Intervention: Minimal contact control condition
Number of subjects: 0
Study 14527092 — intervention group
Group type: EXPERIMENTAL
Intervention: Stepwise estimation
Number of subjects: 36
Study 14527092 — intervention group
Group type: EXPERIMENTAL
Intervention: Simultaneous estimation
Number of subjects: 36
Study 14527092 — intervention group
Group type: EXPERIMENTAL
Intervention: Bootstrap validation
Number of subjects: 36
Study 10920066 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin E 300 mg/d
Number of subjects: 46
Study 10920066 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin E 600 mg/d
Number of subjects: 46
Study 10920066 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin E 1200 mg/d
Number of subjects: 46
Study 10920066 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 46
Study 8632687 — intervention group
Group type: EXPERIMENTAL
Intervention: Medical students, residents, and faculty attitudes toward decision-making input by older patients (75 years old)
Number of subjects: 818
Study 8632687 — intervention group
Group type: EXPERIMENTAL
Intervention: Female respondents
Number of subjects: 818
Study 8632687 — intervention group
Group type: EXPERIMENTAL
Intervention: Residents
Number of subjects: 818
Study 8632687 — intervention group
Group type: EXPERIMENTAL
Intervention: Faculty
Number of subjects: 818
Study 8632687 — intervention group
Group type: EXPERIMENTAL
Intervention: Level of training
Number of subjects: 818
Study 1283984 — intervention group
Group type: EXPERIMENTAL
Intervention: Carbimazole for 12 months (Group I, n = 28)
Number of subjects: 52
Study 1283984 — intervention group
Group type: EXPERIMENTAL
Intervention: Carbimazole for 24 months (Group II, n = 24)
Number of subjects: 52
Study 6531951 — intervention group
Group type: EXPERIMENTAL
Intervention: Single dose of trivalent influenza subunit vaccine (7 micrograms per dose)
Number of subjects: 88
Study 30799237 — intervention group
Group type: EXPERIMENTAL
Intervention: Sebia FLC assay
Number of subjects: 177
Study 30799237 — intervention group
Group type: COMPARATOR
Intervention: Freelite assay
Number of subjects: 177
Study 30068502 — intervention group
Group type: EXPERIMENTAL
Intervention: e-Powered Parents (online program)
Number of subjects: 146
Study 30068502 — intervention group
Group type: COMPARATOR
Intervention: Usual care (control group)
Number of subjects: 146
Study 27241710 — intervention group
Group type: EXPERIMENTAL
Intervention: Levodopa 100 mg/carbidopa 25 mg
Number of subjects: 26
Study 27241710 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 26
Study 24286858 — intervention group
Group type: EXPERIMENTAL
Intervention: Adaptation to a swing phase perturbation on a treadmill
Number of subjects: 20
Study 22156610 — intervention group
Group type: EXPERIMENTAL
Intervention: EBUS‐TBNA
Number of subjects: 115
Study 22156610 — intervention group
Group type: COMPARATOR
Intervention: EBUS‐TBNCS
Number of subjects: 115
Study 20345509 — intervention group
Group type: EXPERIMENTAL
Intervention: Lansoprazole
Number of subjects: 32
Study 18544002 — intervention group
Group type: EXPERIMENTAL
Intervention: Parecoxib 40 mg intravenously every 12 hours for 48 hours
Number of subjects: 50
Study 18544002 — intervention group
Group type: COMPARATOR
Intervention: Dipyrone 2.5 g intravenously intraoperatively, followed by 1 g every 6 hours for 48 hours
Number of subjects: 50
Study 18544002 — intervention group
Group type: EXPERIMENTAL
Intervention: Cumulative piritramide administration
Number of subjects: 50
Study 15669895 — intervention group
Group type: EXPERIMENTAL
Intervention: Citalopram or Paroxetine
Number of subjects: 119
Study 14660265 — intervention group
Group type: EXPERIMENTAL
Intervention: 1.5% ciclopirox olamine shampoo
Number of subjects: 64
Study 14660265 — intervention group
Group type: COMPARATOR
Intervention: 2% ketoconazole shampoo
Number of subjects: 64
Study 11528495 — intervention group
Group type: EXPERIMENTAL
Intervention: Fruit juice (1 l per day)
Number of subjects: 41
Study 11528495 — intervention group
Group type: EXPERIMENTAL
Intervention: Fruit-vegetable-concentrate (30 ml per day)
Number of subjects: 41
Study 11528495 — intervention group
Group type: COMPARATOR
Intervention: Control (HIV-seronegative subjects)
Number of subjects: 41
Study 9371896 — intervention group
Group type: EXPERIMENTAL
Intervention: Zolmitriptan 2.5 mg
Number of subjects: 999
Study 9371896 — intervention group
Group type: EXPERIMENTAL
Intervention: Zolmitriptan doses > or = 2.5 mg
Number of subjects: 999
Study 9371896 — intervention group
Group type: EXPERIMENTAL
Intervention: Zolmitriptan (second dose)
Number of subjects: 999
Study 9371896 — intervention group
Group type: EXPERIMENTAL
Intervention: Zolmitriptan doses < or = 2.5 mg
Number of subjects: 999
Study 9371896 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 999
Study 1553930 — intervention group
Group type: EXPERIMENTAL
Intervention: Fish oil supplementation (4.2 g of omega-3 fatty acids per day)
Number of subjects: 11
Study 1553930 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 11
Study 3993553 — intervention group
Group type: EXPERIMENTAL
Intervention: Atenolol
Number of subjects: 11
Study 3993553 — intervention group
Group type: EXPERIMENTAL
Intervention: Propranolol
Number of subjects: 11
Study 3993553 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 11
Study 30141340 — intervention group
Group type: EXPERIMENTAL
Intervention: Eczema Action Plan (EAP)
Number of subjects: 0
Study 30141340 — intervention group
Group type: COMPARATOR
Intervention: Traditional care
Number of subjects: 0
Study 27982166 — intervention group
Group type: EXPERIMENTAL
Intervention: Radiofrequency ablation
Number of subjects: 18
Study 27982166 — intervention group
Group type: COMPARATOR
Intervention: Conventional surgery
Number of subjects: 18
Study 25242558 — intervention group
Group type: EXPERIMENTAL
Intervention: Ixekizumab 120 mg subcutaneous every 4 weeks during OLE
Number of subjects: 120
Study 25242558 — intervention group
Group type: COMPARATOR
Intervention: Ixekizumab (previously randomized, placebo-controlled trial)
Number of subjects: 120
Study 25242558 — intervention group
Group type: EXPERIMENTAL
Intervention: Ixekizumab during OLE
Number of subjects: 120
Study 22287580 — intervention group
Group type: EXPERIMENTAL
Intervention: Endoscopic sinus surgery (ESS)
Number of subjects: 51
Study 20075184 — intervention group
Group type: EXPERIMENTAL
Intervention: Sodium valproate (500 mg, intravenous)
Number of subjects: 30
Study 20075184 — intervention group
Group type: COMPARATOR
Intervention: Haloperidol (10 mg, intramuscular)
Number of subjects: 30
Study 18774469 — intervention group
Group type: EXPERIMENTAL
Intervention: Screening for prostate cancer
Number of subjects: 267994
Study 18774469 — intervention group
Group type: EXPERIMENTAL
Intervention: Active observation
Number of subjects: 267994
Study 18774469 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 267994
Study 15692541 — intervention group
Group type: EXPERIMENTAL
Intervention: Coblation-assisted intracapsular tonsillectomy
Number of subjects: 101
Study 15692541 — intervention group
Group type: COMPARATOR
Intervention: Electrocautery tonsillectomy
Number of subjects: 101
Study 12593521 — intervention group
Group type: COMPARATOR
Intervention: BDP via metered-dose inhaler (MDI) 1,600 microg
Number of subjects: 12
Study 12593521 — intervention group
Group type: EXPERIMENTAL
Intervention: BDP suspension for nebulization 1,600 microg
Number of subjects: 12
Study 12593521 — intervention group
Group type: EXPERIMENTAL
Intervention: BDP suspension for nebulization 3,200 microg
Number of subjects: 12
Study 12165579 — intervention group
Group type: EXPERIMENTAL
Intervention: Single remote course of antenatal corticosteroids (two 12‐mg doses of betamethasone)
Number of subjects: 37
Study 12165579 — intervention group
Group type: COMPARATOR
Intervention: Weekly courses of antenatal corticosteroids
Number of subjects: 37
Study 10660867 — intervention group
Group type: EXPERIMENTAL
Intervention: Caffeine (5 mg.kg-1)
Number of subjects: 8
Study 10660867 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8
Study 7789043 — intervention group
Group type: EXPERIMENTAL
Intervention: Clonidine (infusion rates of 16-2048 ng/min)
Number of subjects: 44
Study 7789043 — intervention group
Group type: EXPERIMENTAL
Intervention: Phenylephrine
Number of subjects: 44
Study 7789043 — intervention group
Group type: COMPARATOR
Intervention: Control (non-diabetic subjects)
Number of subjects: 44
Study 2314446 — intervention group
Group type: EXPERIMENTAL
Intervention: Proton nuclear magnetic resonance (NMR) spectroscopy in plasma samples from patients with cancer
Number of subjects: 268
Study 2314446 — intervention group
Group type: COMPARATOR
Intervention: Proton nuclear magnetic resonance (NMR) spectroscopy in plasma samples from healthy controls
Number of subjects: 268
Study 2314446 — intervention group
Group type: COMPARATOR
Intervention: Proton NMR spectroscopy in male controls 40 years old or older
Number of subjects: 268
Study 2314446 — intervention group
Group type: COMPARATOR
Intervention: Proton NMR spectroscopy in female controls 40 years old or older
Number of subjects: 268
Study 2314446 — intervention group
Group type: EXPERIMENTAL
Intervention: Proton NMR spectroscopy in women with cancer
Number of subjects: 268
Study 2314446 — intervention group
Group type: EXPERIMENTAL
Intervention: Proton NMR spectroscopy in men with cancer
Number of subjects: 268
Study 6107587 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous and oral disopyramide
Number of subjects: 199
Study 6107587 — intervention group
Group type: COMPARATOR
Intervention: Matching placebo
Number of subjects: 199
Study 6652010 — intervention group
Group type: COMPARATOR
Intervention: Morphine 10 mg i.m.
Number of subjects: 30
Study 6652010 — intervention group
Group type: EXPERIMENTAL
Intervention: Morphine 5 mg into the extradural space
Number of subjects: 30
Study 31663833 — intervention group
Group type: EXPERIMENTAL
Intervention: Titanium mesh cages (TMC)
Number of subjects: 146
Study 31663833 — intervention group
Group type: COMPARATOR
Intervention: Autogenous iliac bone grafts (AIBG)
Number of subjects: 146
Study 31663833 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (TMC and AIBG)
Number of subjects: 146
Study 31053510 — intervention group
Group type: EXPERIMENTAL
Intervention: Vegetable first, followed by meat and rice (V-M-R)
Number of subjects: 16
Study 31053510 — intervention group
Group type: EXPERIMENTAL
Intervention: Meat first, followed by vegetable and rice (M-VR)
Number of subjects: 16
Study 31053510 — intervention group
Group type: EXPERIMENTAL
Intervention: Vegetable, meat and rice consumed together (VMR)
Number of subjects: 16
Study 31053510 — intervention group
Group type: COMPARATOR
Intervention: Rice consumed first followed by vegetable and meat (R-VM)
Number of subjects: 16
Study 31053510 — intervention group
Group type: EXPERIMENTAL
Intervention: Vegetable first followed by meat and rice (V-M-R)
Number of subjects: 16
Study 29774465 — intervention group
Group type: EXPERIMENTAL
Intervention: 4000 mg myo-inositol plus 400 mcg folic acid (MI treatment)
Number of subjects: 80
Study 29774465 — intervention group
Group type: EXPERIMENTAL
Intervention: 500 mg D-chiro-inositol plus 400 mcg folic acid (DCI treatment)
Number of subjects: 80
Study 29774465 — intervention group
Group type: EXPERIMENTAL
Intervention: 1100/27.6 mg myo/D-chiro-inositol plus 400 mcg folic acid (MI plus DCI treatment)
Number of subjects: 80
Study 29774465 — intervention group
Group type: COMPARATOR
Intervention: 400 mcg folic acid (control treatment)
Number of subjects: 80
Study 27760402 — intervention group
Group type: EXPERIMENTAL
Intervention: CC-60 (21 mg/day carotenes)
Number of subjects: 90
Study 27760402 — intervention group
Group type: EXPERIMENTAL
Intervention: TRF-80 (420 mg/day tocotrienol + 132 mg/day tocopherol)
Number of subjects: 90
Study 27760402 — intervention group
Group type: COMPARATOR
Intervention: Placebo (palm olein)
Number of subjects: 90
Study 24923573 — intervention group
Group type: EXPERIMENTAL
Intervention: Filiform needles (acupuncture)
Number of subjects: 58
Study 24923573 — intervention group
Group type: COMPARATOR
Intervention: Thumbtack intradermal (TI) needles (control)
Number of subjects: 58
Study 22836707 — intervention group
Group type: EXPERIMENTAL
Intervention: Tai Chi (50 min daily training for 6 months)
Number of subjects: 55
Study 22836707 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 55
Study 20555293 — intervention group
Group type: EXPERIMENTAL
Intervention: Chlorhexidine gel
Number of subjects: 694
Study 20555293 — intervention group
Group type: COMPARATOR
Intervention: Aqueous chlorhexidine
Number of subjects: 694
Study 20555293 — intervention group
Group type: EXPERIMENTAL
Intervention: Household-level acceptability study
Number of subjects: 694
Study 18453389 — intervention group
Group type: EXPERIMENTAL
Intervention: Mortality-related health-risk information about driving
Number of subjects: 339
Study 18453389 — intervention group
Group type: EXPERIMENTAL
Intervention: Prime to behave responsibly alongside mortality-related information
Number of subjects: 339
Study 16168152 — intervention group
Group type: EXPERIMENTAL
Intervention: COPE
Number of subjects: 91
Study 16168152 — intervention group
Group type: COMPARATOR
Intervention: No‐COPE
Number of subjects: 91
Study 12673150 — intervention group
Group type: EXPERIMENTAL
Intervention: Resistance training (BR-Tr group: N = 6)
Number of subjects: 12
Study 12673150 — intervention group
Group type: COMPARATOR
Intervention: Nontraining (BR-Cont group: N = 6)
Number of subjects: 12
Study 10727068 — intervention group
Group type: EXPERIMENTAL
Intervention: IR120 (7 bouts of 120 s runs with 120 s rest)
Number of subjects: 10
Study 10727068 — intervention group
Group type: COMPARATOR
Intervention: IR60 (14 bouts of 60 s runs with 60 s rest)
Number of subjects: 10
Study 8789545 — intervention group
Group type: EXPERIMENTAL
Intervention: Cetirizine (30 mg daily for 5 days)
Number of subjects: 12
Study 8789545 — intervention group
Group type: EXPERIMENTAL
Intervention: Prednisolone (20 mg daily for 5 days)
Number of subjects: 12
Study 1615546 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous glycerol (500 ml of 10% glycerol in saline by intravenous infusion over 4 hours on 6 consecutive days)
Number of subjects: 216
Study 1615546 — intervention group
Group type: COMPARATOR
Intervention: Saline treatment (placebo)
Number of subjects: 216
Study 1615546 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous glycerol
Number of subjects: 216
Study 6495087 — intervention group
Group type: EXPERIMENTAL
Intervention: Intramuscular atropine
Number of subjects: 25
Study 6495087 — intervention group
Group type: EXPERIMENTAL
Intervention: Intramuscular glycopyrrolate
Number of subjects: 25
Study 31143882 — intervention group
Group type: EXPERIMENTAL
Intervention: CC‐Cruiser
Number of subjects: 350
Study 31143882 — intervention group
Group type: COMPARATOR
Intervention: Senior consultants
Number of subjects: 350
Study 30241687 — intervention group
Group type: EXPERIMENTAL
Intervention: Pregabalin 300 mg BID for 6 times
Number of subjects: 42
Study 30241687 — intervention group
Group type: EXPERIMENTAL
Intervention: Thioctic acid 600 mg once daily for 3 times
Number of subjects: 42
Study 30241687 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of pregabalin and thioctic acid
Number of subjects: 42
Study 30241687 — intervention group
Group type: COMPARATOR
Intervention: Control (no treatment)
Number of subjects: 42
Study 26969528 — intervention group
Group type: EXPERIMENTAL
Intervention: Neuromuscular electrical stimulation (NMES) combined with effortful swallowing
Number of subjects: 50
Study 26969528 — intervention group
Group type: COMPARATOR
Intervention: Placebo group (NMES with electrical sensation)
Number of subjects: 50
Study 24708735 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral dose of 50,000 IU vitamin A
Number of subjects: 200
Study 24708735 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 200
Study 22488716 — intervention group
Group type: EXPERIMENTAL
Intervention: Microwave ablation
Number of subjects: 102
Study 22488716 — intervention group
Group type: COMPARATOR
Intervention: Partial nephrectomy
Number of subjects: 102
Study 20081227 — intervention group
Group type: EXPERIMENTAL
Intervention: Triple therapy (cilostazol, thienopyridine, aspirin)
Number of subjects: 1597
Study 20081227 — intervention group
Group type: COMPARATOR
Intervention: Dual therapy (thienopyridine, aspirin)
Number of subjects: 1597
Study 20081227 — intervention group
Group type: EXPERIMENTAL
Intervention: Triple therapy
Number of subjects: 1597
Study 20081227 — intervention group
Group type: COMPARATOR
Intervention: Triple therapy and Dual therapy
Number of subjects: 1597
Study 19097974 — intervention group
Group type: EXPERIMENTAL
Intervention: BB condition (bulletin board)
Number of subjects: 1375
Study 19097974 — intervention group
Group type: COMPARATOR
Intervention: UC condition (usual care)
Number of subjects: 1375
Study 19097974 — intervention group
Group type: EXPERIMENTAL
Intervention: Participants who attempted to quit within a few days of study entry
Number of subjects: 1375
Study 15829326 — intervention group
Group type: EXPERIMENTAL
Intervention: EP (etoposide and cisplatin)
Number of subjects: 286
Study 15829326 — intervention group
Group type: EXPERIMENTAL
Intervention: CEV (cyclophosphamide, epirubicin, vincristine)
Number of subjects: 286
Study 15829326 — intervention group
Group type: COMPARATOR
Intervention: Best supportive care
Number of subjects: 286
Study 12052603 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravaginal misoprostol moistened with 1 mL of 3% acetic acid solution
Number of subjects: 177
Study 12052603 — intervention group
Group type: COMPARATOR
Intervention: Intravaginal misoprostol in dry tablet form
Number of subjects: 177
Study 12052603 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 177
Study 10397281 — intervention group
Group type: EXPERIMENTAL
Intervention: Alcohol (0.5 g/kg) in OC+ subjects
Number of subjects: 61
Study 10397281 — intervention group
Group type: EXPERIMENTAL
Intervention: Alcohol (0.5 g/kg) in OC- subjects
Number of subjects: 61
Study 10397281 — intervention group
Group type: EXPERIMENTAL
Intervention: Alcohol (0.5 g/kg) in both OC+ and OC- subjects
Number of subjects: 61
Study 10397281 — intervention group
Group type: EXPERIMENTAL
Intervention: Alcohol (0.5 g/kg) in OC+ subjects during midcycle
Number of subjects: 61
Study 10397281 — intervention group
Group type: EXPERIMENTAL
Intervention: Alcohol (0.34-1.02 g/kg) in OC+ subjects (substudy)
Number of subjects: 61
Study 8800888 — intervention group
Group type: EXPERIMENTAL
Intervention: Side‐fire laser prostatectomy
Number of subjects: 40
Study 8800888 — intervention group
Group type: EXPERIMENTAL
Intervention: Side‐fire laser with debridement
Number of subjects: 40
Study 8800888 — intervention group
Group type: COMPARATOR
Intervention: TURP
Number of subjects: 40
Study 8800888 — intervention group
Group type: EXPERIMENTAL
Intervention: All groups after 1 year
Number of subjects: 40
Study 2004941 — intervention group
Group type: EXPERIMENTAL
Intervention: Delayed split whole abdominal irradiation (DSA)
Number of subjects: 58
Study 6577774 — intervention group
Group type: EXPERIMENTAL
Intervention: High volume water intake (excess volume)
Number of subjects: 190
Study 6577774 — intervention group
Group type: COMPARATOR
Intervention: Low volume water intake (average estimated requirement)
Number of subjects: 190
Study 29627620 — intervention group
Group type: EXPERIMENTAL
Intervention: LUB 12 μg
Number of subjects: 150
Study 29627620 — intervention group
Group type: EXPERIMENTAL
Intervention: LUB 24 μg
Number of subjects: 150
Study 29627620 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 150
Study 25252727 — intervention group
Group type: EXPERIMENTAL
Intervention: 500 mg of cefetamet sodium for IV infusion over 30 minutes
Number of subjects: 12
Study 25252727 — intervention group
Group type: EXPERIMENTAL
Intervention: 1000 mg of cefetamet sodium for IV infusion over 30 minutes
Number of subjects: 12
Study 25252727 — intervention group
Group type: EXPERIMENTAL
Intervention: 2000 mg of cefetamet sodium for IV infusion over 30 minutes
Number of subjects: 12
Study 25571864 — intervention group
Group type: EXPERIMENTAL
Intervention: Pelvic floor muscle (PFM) exercise education intervention (Group A)
Number of subjects: 145
Study 25571864 — intervention group
Group type: EXPERIMENTAL
Intervention: First education intervention (Group B)
Number of subjects: 145
Study 25571864 — intervention group
Group type: COMPARATOR
Intervention: Control group (Group C)
Number of subjects: 145
Study 23949430 — intervention group
Group type: EXPERIMENTAL
Intervention: Dinaciclib 50 mg/m² given as a 2-h infusion every 21 days
Number of subjects: 20
Study 20886398 — intervention group
Group type: EXPERIMENTAL
Intervention: Radiofrequency ablation (RFA)
Number of subjects: 127
Study 20886398 — intervention group
Group type: COMPARATOR
Intervention: Sham intervention
Number of subjects: 127
Study 18563333 — intervention group
Group type: EXPERIMENTAL
Intervention: Short-segment pedicle screw fixation with posterior morselized bone grafting (Group A)
Number of subjects: 70
Study 18563333 — intervention group
Group type: COMPARATOR
Intervention: Short-segment pedicle screw fixation without morselized bone grafting (Group B)
Number of subjects: 70
Study 15858936 — intervention group
Group type: EXPERIMENTAL
Intervention: Nitroglycerin (3 microg/kg) added to the cardioplegic solution
Number of subjects: 30
Study 15858936 — intervention group
Group type: COMPARATOR
Intervention: Placebo (3 microg/kg) added to the cardioplegic solution
Number of subjects: 30
Study 14503094 — intervention group
Group type: EXPERIMENTAL
Intervention: Telithromycin for 5 days
Number of subjects: 754
Study 14503094 — intervention group
Group type: EXPERIMENTAL
Intervention: Telithromycin for 10 days
Number of subjects: 754
Study 14503094 — intervention group
Group type: COMPARATOR
Intervention: Amoxicillin/clavulanic acid for 10 days
Number of subjects: 754
Study 10374221 — intervention group
Group type: EXPERIMENTAL
Intervention: Estrogen-androgen therapy (0.625 mg esterified estrogens combined with 1.25 mg methyltestosterone)
Number of subjects: 93
Study 10374221 — intervention group
Group type: EXPERIMENTAL
Intervention: Estrogen-androgen therapy (1.25 mg esterified estrogens combined with 2.5 mg methyltestosterone)
Number of subjects: 93
Study 10374221 — intervention group
Group type: COMPARATOR
Intervention: Estrogen-only therapy (0.625 mg esterified estrogens)
Number of subjects: 93
Study 10374221 — intervention group
Group type: COMPARATOR
Intervention: Estrogen-only therapy (1.25 mg esterified estrogens)
Number of subjects: 93
Study 10374221 — intervention group
Group type: EXPERIMENTAL
Intervention: Estrogen-androgen therapy
Number of subjects: 93
Study 10374221 — intervention group
Group type: COMPARATOR
Intervention: Estrogen treatment
Number of subjects: 93